1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. IMMUNITYBIO INC
ImmunityBio Inc XNAS: IBRX
2.26 -0.14 (-5.83%)
9.0M
XNAS Volume

XNAS 03 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for ImmunityBio Inc is on 12 Nov 2025 for the purpose of ImmunityBio Inc Third Quarter Earnings Results for 2025 See details

ImmunityBio Inc - IBRX - stock price prediction, stock price target, analyst ratings from 5 analysts

ImmunityBio Inc has a share price target of US$ 10, revenue growth forecast of 646.8%, and profit growth estimate of 0.1% for FY25, based on top 5 analyst calls.